Neuroprotective mechanisms of SMTP-7 in cerebral infarction model in mice

Naunyn Schmiedebergs Arch Pharmacol. 2011 Jul;384(1):103-8. doi: 10.1007/s00210-011-0642-x. Epub 2011 May 2.

Abstract

Reactive oxygen species (ROS) formation has been found to induce the brain damage following stroke-like events. The aim of the present study was to investigate the effect of Stachybotrys microspora triprenyl phenol-7 (SMTP-7) on the generation of ROS in ischemia-induced cerebral infarction model and in vitro lipid peroxidation. We used immunohistochemistry and real-time reverse-transcription PCR for ex vivo evaluation and thiobarbituric acid-reactive substance reagent assay for in vitro evaluation. We demonstrated that SMTP-7 did not induce enhancement of 4-hydroxynonenal or neutrophil cytosolic factor 2 like t-PA administration at 3 h after ischemia ex vivo and reduce lipid peroxidation in vitro. This compound is the first low molecular weight compound with triplet activities of thrombolytic, anti-inflammatory, and antioxidant activities. We theorized that SMTP-7 is among the pharmacological agents that reduce ROS formation and have been found to limit the extent of brain damage following stroke-like events.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aldehydes / metabolism
  • Animals
  • Antipyrine / analogs & derivatives
  • Antipyrine / pharmacology
  • Benzopyrans / pharmacology*
  • Benzopyrans / therapeutic use
  • Brain / drug effects
  • Brain / metabolism
  • Cerebral Infarction / drug therapy
  • Cerebral Infarction / metabolism
  • Cerebral Infarction / prevention & control*
  • Disease Models, Animal
  • Edaravone
  • Ferrous Compounds / pharmacology
  • Free Radical Scavengers / pharmacology
  • Free Radical Scavengers / therapeutic use
  • Gene Expression / drug effects
  • Gene Expression / genetics
  • Lipid Peroxidation / drug effects
  • Male
  • Mice
  • Mice, Inbred Strains
  • NADPH Oxidases / genetics
  • Neuroprotective Agents / pharmacology*
  • Neuroprotective Agents / therapeutic use
  • Pyrrolidinones / pharmacology*
  • Pyrrolidinones / therapeutic use
  • Reactive Oxygen Species / metabolism
  • Real-Time Polymerase Chain Reaction
  • Thiobarbituric Acid Reactive Substances / metabolism
  • Tissue Plasminogen Activator / pharmacology
  • Tissue Plasminogen Activator / therapeutic use

Substances

  • Aldehydes
  • Benzopyrans
  • Ferrous Compounds
  • Free Radical Scavengers
  • Neuroprotective Agents
  • Pyrrolidinones
  • Reactive Oxygen Species
  • SMTP 7
  • Thiobarbituric Acid Reactive Substances
  • NADPH Oxidases
  • Ncf2 protein, mouse
  • Tissue Plasminogen Activator
  • 4-hydroxy-2-nonenal
  • Edaravone
  • Antipyrine